Haridwar Unit-II
Haridwar Unit-II
Oncology Facility
Location: Haridwar (Unit-II)
Plant Area:35000 Sqft.
Key Highlights
- State-of-the-art US-FDA compliant oncology plant at Haridwar (India).
- Rollout of globally oncology formulations.
Capacity of Oncology Facility
- Oral Solid Dose (OSD) Section
- Integrated Granulation line (Glatt , 30 Kg capacity) with WIP technology & interchangeable bowl size.
- Tablet compression & encapsulation with Isolators
- Tablet coater with WIP technology (Glatt)
- Tablet formulation capacity - 140 million per annum.
- Capsules capacity- 4.5 million per annum.
- Injectable Section :
- Lyophilized vials capacity - 2 to 2.25 million per annum.
- RTU vials capacity - 5 to 5.55 million per annum..